Prof. Chris Toumazou
Regius Professor of Engineering, Chair in Biomedical Circuit Design, Director of the Centre for Bio-Inspired Technology and Founder and Chief Scientist for the Institute of Biomedical Engineering at Imperial College. He is also Founder, Chairman or CEO of two successful medical device companies (Toumaz Technology and DNA Electronics) and Chief Scientific Advisor to GENEU.
He is distinguished for his innovative silicon technology and integrated circuit design for electronic device in the field of devices for medical diagnosis and therapy. Professor Toumazou is pre-eminent amongst the global community of contemporary medical engineers. In 1994 Toumazou was appointed the youngest Professor ever to be appointed at Imperial College, at the age of 33. In 2013 he became London’s First Regius Professor of Engineering conferred to Imperial College during the Queen’s Diamond Jubilee.
Toumazou’s research include cochlear implants for born-deaf children, an artificial pancreas for type 1 diabetics, wireless heart monitors for personalised ambulatory health monitoring pre- and post- operatively, inventing semiconductor-based DNA sequencing and inventing an intelligent neural stimulator as a drug alternative for obesity. In this and many other areas he has published over 750 research papers, holds over 50 patents and employs over 300 people in his combined medical device companies and Institute of Biomedical engineering at Imperial College London.